{{Drugbox
| verifiedrevid = 461766301
| IUPAC_name = 3-(Dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]-1-propanol
| image = Halofantrine.svg

<!--Clinical data-->
| tradename = Halfan
| Drugs.com = {{drugs.com|CDI|halofantrine}}
| MedlinePlus = a603030
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| protein_bound = 60–70%
| metabolism = [[Liver|Hepatic]] ([[CYP3A4|CYP3A4]]-mediated)
| elimination_half-life = 6–10 days

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 69756-53-2
| ATC_prefix = P01
| ATC_suffix = BX01
| PubChem = 37393
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01218
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 34303
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q2OS4303HZ
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1107

<!--Chemical data-->
| C=26 | H=30 | Cl=2 | F=3 | N=1 | O=1
| molecular_weight = 500.423 g/mol
| smiles = FC(F)(F)c3ccc2c(cc1c(Cl)cc(Cl)cc1c2c3)C(O)CCN(CCCC)CCCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FOHHNHSLJDZUGQ-UHFFFAOYSA-N
}}
{{roughtranslation|time=2018-07-15T17:32:17+00:00}}
卤泛群（又名'''卤泛曲林'''、'''氯氟菲醇'''）是一种用于治疗疟疾的药物， 其主要结构是含有取代基的[[菲|菲]]，与抗疟药[[奎寧|奎宁]]和[[苯芴醇|苯芴醇]]有关。卤泛群从未用于预防疟疾，因为其作用机理未知，尽管晶体学研究表明它在体外可与血红素结合，提示是其可能的作用机制<ref>{{Cite journal|title=The crystal structure of halofantrine-ferriprotoporphyrin IX and the mechanism of action of arylmethanol antimalarials|url=https://www.ncbi.nlm.nih.gov/pubmed/18508124|last=de Villiers|first=Katherine A.|last2=Marques|first2=Helder M.|date=2008-8|journal=Journal of Inorganic Biochemistry|issue=8|doi=10.1016/j.jinorgbio.2008.04.001|volume=102|pages=1660–1667|issn=1873-3344|pmid=18508124|last3=Egan|first3=Timothy J.}}</ref>。卤泛群也被证明可以与天冬氨酸蛋白酶结合，这是一种疟原虫独有的血红蛋白降解酶<ref>{{Cite journal|title=Discovery of plasmepsin inhibitors by fragment-based docking and consensus scoring|url=https://www.ncbi.nlm.nih.gov/pubmed/19472268|last=Friedman|first=Ran|last2=Caflisch|first2=Amedeo|date=2009-8|journal=ChemMedChem|issue=8|doi=10.1002/cmdc.200900078|volume=4|pages=1317–1326|issn=1860-7187|pmid=19472268}}</ref>。

卤泛群是由药物化学家William Colwell领导的团队于1965年至1975年在史丹福国际研究中心为沃尔特•里德陆军研究所开发的<ref>{{Cite book|url=https://www.worldcat.org/oclc/180190280|last=L.|first=Nielson, Donald|date=2006|publisher=SRI International|isbn=9780974520810|edition=1st ed. (rev.)|location=Menlo Park, Calif.|chapter=A heritage of innovation : SRI's first half century|oclc=180190280}}</ref>。

== 不良反应 ==
卤泛群可引起腹痛，腹泻，呕吐，皮疹，头痛，瘙痒和肝转氨酶升高。

据报道可能与心脏毒性有关<ref>{{Cite journal|title=Mechanism of cardiotoxicity of halofantrine|url=https://www.ncbi.nlm.nih.gov/pubmed/10824631|last=Wesche|first=D. L.|last2=Schuster|first2=B. G.|date=2000-5|journal=Clinical Pharmacology and Therapeutics|issue=5|doi=10.1067/mcp.2000.106127|volume=67|pages=521–529|issn=0009-9236|pmid=10824631|last3=Wang|first3=W. X.|last4=Woosley|first4=R. L.}}</ref>。最危险的副作用是心律失常：引起显着的QT延长<ref>{{Cite journal|title=Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine|url=https://www.ncbi.nlm.nih.gov/pubmed/15558243|last=Sánchez-Chapula|first=José A.|last2=Navarro-Polanco|first2=Ricardo A.|date=2004-12|journal=Naunyn-Schmiedeberg's Archives of Pharmacology|issue=6|doi=10.1007/s00210-004-0995-5|volume=370|pages=484–491|issn=0028-1298|pmid=15558243|last3=Sanguinetti|first3=Michael C.}}</ref>，甚至在标准剂量下也能看到这种副作用。因此，患有心脏传导缺陷的患者不宜使用，不应与甲氟喹合用。 2009年的一项调查表明，正确的方式使用该药物是安全的<ref>{{Cite journal|title=Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base|url=https://www.ncbi.nlm.nih.gov/pubmed/20003315|last=Bouchaud|first=Olivier|last2=Imbert|first2=Patrick|date=2009-12-10|journal=Malaria Journal|doi=10.1186/1475-2875-8-289|volume=8|pages=289|issn=1475-2875|pmc=2801676|pmid=20003315|last3=Touze|first3=Jean Etienne|last4=Dodoo|first4=Alex N. O.|last5=Danis|first5=Martin|last6=Legros|first6=Fabrice}}</ref>。

卤泛群与葡萄柚汁混合是危险的。葡萄柚汁作用机制是抑制CYP3A4，CYP3A4是卤泛群代谢并将其从体内消除所必需的。没有CYP3A4，卤泛群的水平将在体内变得有毒。

== 药理学 ==
卤泛群的作用机制尚不清楚。卤泛群的吸收不稳定，与脂肪食物一起服用时会增加。由于担心由于卤泛群在血液中水平增加而引起的毒性，应该空腹服用卤泛群。 

血浆水平在16小时达到峰值，药物的半衰期约为4天。
==参考文献==
<references />
{{Chromalveolate antiparasitics}}
[[Category:醇盐|Category:醇盐]]
[[Category:抗疟疾剂|Category:抗疟疾剂]]
[[Category:氯代芳烴|Category:氯代芳烴]]
[[Category:三氟甲基化合物|Category:三氟甲基化合物]]
[[Category:菲|Category:菲]]